Antibiotic-resistant gram-negative bacteria in hospitalized children

Clinics in Laboratory Medicine

Volumn 24, Issue 2, 2004, Pages 363-380

  Toltzis, Philip ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CEPHALOSPORIN; PENICILLIN G;

ACINETOBACTER; AMINO ACID SUBSTITUTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ANTISEPSIS; BACTERIAL CELL WALL; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BLOOD FLOW; CAREGIVER; CHILD; CHILD HOSPITALIZATION; CITROBACTER; CRITICAL ILLNESS; ENTEROBACTER; FINGER NAIL; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HAND WASHING; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA; NEWBORN INTENSIVE CARE; NONHUMAN; PEDIATRIC HOSPITAL; PENICILLIN RESISTANCE; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; REVIEW; SERRATIA;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN;

EID: 2942536395     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.03.001     Document Type: Review

References (124)

1. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 39:(6):1995;1211-1233
2. Heritage J., M'Zali F.H., Gascoyne-Binzi D., Hawkey P.M. Evolution and spread of SHV extended-spectrum beta-lactamases in gram- negative bacteria. J Antimicrob Chemother. 44:(3):1999;309-318
3. Chaibi E.B., Sirot D., Paul G., Labia R. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother. 43:(4):1999;447-458
4. Du Bois S.K., Marriott M.S., Amyes S.G. TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function. J Antimicrob Chemother. 35:(1):1995;7-22
5. Knox J.R. Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob Agents Chemother. 39:(12):1995;2593-2601
6. Medeiros A.A. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis. 24:(Suppl 1):1997;S19-S45
7. Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis. 32:(7):2001;1085-1089
8. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev. 57:(1):1993;138-163
9. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 34:(5):2002;634-640
10. Paterson D.L., Mulazimoglu L., Casellas J.M., et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 30:(3):2000;473-478
11. Martinez-Martinez L., Pascual A., Hernandez-Alles S., et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother. 43:(7):1999;1669- 1673
12. Chevalier J., Pages J.M., Eyraud A., Mallea M. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem Biophys Res Commun. 274:(2):2000;496-499
13. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis. 27:(Suppl 1):1998;S32-S41
14. Hooper D.C. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 32:(Suppl 1):2001;S9-S15
15. Sirot D.L., Goldstein F.W., Soussy C.J., et al. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother. 36:(8):1992;1677-1681
16. Burwen D.R., Banerjee S.N., Gaynes R.P. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis. 170:(6):1994;1622-1625
17. Legakis N.J., Tzouvelekis L.S., Tsakris A., Legakis J.N., Vatopoulos A.C. On the incidence of antibiotic resistance among aerobic gram-negative rods isolated in Greek hospitals. J Hosp Infect. 24:(3):1993;233-237
18. Dornbusch K., King A., Legakis N. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients. Report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis. 30:(3):1998;281-288
19. Flournoy D.J., Reinert R.L., Bell-Dixon C., Gentry C.A. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control. 28:(3):2000;244-250
20. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nilsson L.E., Struelens M.J. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 281:(1):1999;67-71
21. Aksaray S., Dokuzoguz B., Guvener E., et al. Surveillance of antimicrobial resistance among gram-negative isolates from intensive care units in eight hospitals in turkey. J Antimicrob Chemother. 46:(4):2000;649
22. Itokazu G.S., Quinn J.P., Bell-Dixon C., Kahan F.M., Weinstein R.A. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis. 23:(4):1996;779-784
23. Jarlier V., Fosse T., Philippon A. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med. 22:(10):1996;1057-1065
24. Turner P.J. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview. J Antimicrob Chemother. 46:(Suppl B):2000;9-23
25. Winokur P.L., Canton R., Casellas J.M., Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis. 32:(Suppl 2):2001;S94-S103
26. Babini G.S., Livermore D.M. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 45:(2):2000;183-189
27. Diekema D.J., Pfaller M.A., Jones R.N., et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis. 29:(3):1999;595-607
28. Schmitz F.J., Fluit A.C., Gondolf M., et al. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother. 43:(2):1999;253-259
29. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis. 30:(3):2000;454-460
30. Goettsch W., van Pelt W., Nagelkerke N., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother. 46:(2):2000;223-228
31. Stoll B.J., Hansen N., Fanaroff A.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 110:(2 Pt 1):2002;285-291
32. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 103:(4):1999;e39
33. Grohskopf L.A., Sinkowitz-Cochran R.L., Garrett D.O., et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr. 140:(4):2002;432-438
34. Raymond J., Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol. 21:(4):2000;260-263
35. Wisplinghoff H., Seifert H., Tallent S.M., Bischoff T., Wenzel R.P., Edmond M.B. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 22:(8):2003;686-691
36. Schrag S.J., Zywicki S., Farley M.M., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 342:(1):2000;15-20
37. Baltimore R.S., Huie S.M., Meek J.I., Schuchat A., O'Brien K.L. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 108:(5):2001;1094-1098
38. Hyde T.B., Hilger T.M., Reingold A., Farley M.M., O'Brien K.L., Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 110:(4):2002;690-695
39. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 347:(4):2002;240-247
40. Schuchat A., Zywicki S.S., Dinsmoor M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 105:(1 Pt 1):2000;21-26
41. Shah S.S., Ehrenkranz R.A., Gallagher P.G. Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit. Pediatr Infect Dis J. 18:(7):1999;591-595
42. Nambiar S., Singh N. Change in epidemiology of health care-associated infections in a neonatal intensive care unit. Pediatr Infect Dis J. 21:(9):2002;839-842
43. Singh N., Patel K.M., Leger M.M., et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J. 21:(11):2002;1029-1033
44. Toltzis P., Dul M.J., Hoyen C., et al. Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period. Pediatrics. 108:(5):2001;1143-1148
45. Toltzis P., Yamashita T., Vilt L., Blumer J.L. Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unit. Crit Care Med. 25:(3):1997;538-544
46. Celkan T., Ozkan A., Apak H., et al. Bacteremia in childhood cancer. J Trop Pediatr. 48:(6):2002;373-377
47. Aquino V.M., Pappo A., Buchanan G.R., Tkaczewski I., Mustafa M.M. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J. 14:(2):1995;140-143
48. Aledo A., Heller G., Ren L., et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol. 20:(3):1998;215-221
49. Krupova I., Kaiserova E., Foltinova A., et al. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. J Chemother. 10:(3):1998;236-242
50. Cosgrove S.E., Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 36:(11):2003;1433-1437
51. Osmon S., Warren D., Seiler S.M., Shannon W., Fraser V.J., Kollef M.H. The influence of infection on hospital mortality for patients requiring >48 h of intensive care. Chest. 124:(3):2003;1021-1029
52. Digiovine B., Chenoweth C., Watts C., Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 160:(3):1999;976-981
53. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 118:(1):2000;146-155
54. Carmeli Y., Troillet N., Karchmer A.W., Samore M.H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 159:(10):1999;1127-1132
55. Cosgrove S.E., Kaye K.S., Eliopoulous G.M., Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med. 162:(2):2002;185-190
56. Harbarth S., Rohner P., Auckenthaler R., Safran E., Sudre P., Pittet D. Impact and pattern of gram-negative bacteraemia during 6 y at a large university hospital. Scand J Infect Dis. 31:(2):1999;163-168
57. Blot S., Vandewoude K., De Bacquer D., Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 34:(12):2002;1600-1606
58. Levy I., Leibovici L., Drucker M., Samra Z., Konisberger H., Ashkenazi S. A prospective study of Gram-negative bacteremia in children. Pediatr Infect Dis J. 15:(2):1996;117-122
59. Kartali G., Tzelepi E., Pournaras S., et al. Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital. Antimicrob Agents Chemother. 46:(5):2002;1577-1580
60. v Dijk Y., Bik E.M., Hochstenbach-Vernooij S., et al. Management of an outbreak of Enterobacter cloacae in a neonatal unit using simple preventive measures. J Hosp Infect. 51:(1):2002;21-26
61. van Acker J., de Smet F., Muyldermans G., Bougatef A., Naessens A., Lauwers S. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol. 39:(1):2001;293-297
62. van den Berg R.W., Claahsen H.L., Niessen M., Muytjens H.L., Liem K., Voss A. Enterobacter cloacae outbreak in the NICU related to disinfected thermometers. J Hosp Infect. 45:(1):2000;29-34
63. Tresoldi A.T., Padoveze M.C., Trabasso P., et al. Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution. Am J Infect Control. 28:(3):2000;258-261
64. Yu W.L., Cheng H.S., Lin H.C., Peng C.T., Tsai C.H. Outbreak investigation of nosocomial Enterobacter cloacae bacteraemia in a neonatal intensive care unit. Scand J Infect Dis. 32:(3):2000;293-298
65. Liu S.C., Leu H.S., Yen M.Y., Lee P.I., Chou M.C. Study of an outbreak of Enterobacter cloacae sepsis in a neonatal intensive care unit: the application of epidemiologic chromosome profiling by pulsed-field gel electrophoresis. Am J Infect Control. 30:(7):2002;381-385
66. Fernandez-Baca V., Ballesteros F., Hervas J.A., et al. Molecular epidemiological typing of Enterobacter cloacae isolates from a neonatal intensive care unit: three-year prospective study. J Hosp Infect. 49:(3):2001;173-182
67. Peters S.M., Bryan J., Cole M.F. Enterobacterial repetitive intergenic consensus polymerase chain reaction typing of isolates of Enterobacter cloacae from an outbreak of infection in a neonatal intensive care unit. Am J Infect Control. 28:(2):2000;123-129
68. Cotton M.F., Wasserman E., Pieper C.H., et al. Invasive disease due to extended spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: the possible role of cockroaches. J Hosp Infect. 44:(1):2000;13-17
69. Gonzalez-Vertiz A., Alcantar-Curiel D., Cuauhtli M., et al. Multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae causing an outbreak of nosocomial bloodstream infection. Infect Control Hosp Epidemiol. 22:(11):2001;723-725
70. Berthelot P., Grattard F., Patural H., et al. Nosocomial colonization of premature babies with Klebsiella oxytoca: probable role of enteral feeding procedure in transmission and control of the outbreak with the use of gloves. Infect Control Hosp Epidemiol. 22:(3):2001;148-151
71. Jeong S.H., Kim W.M., Chang C.L., et al. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase. J Hosp Infect. 48:(4):2001;281-288
72. Lebessi E., Dellagrammaticas H., Tassios P.T., et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece. J Clin Microbiol. 40:(3):2002;799-804
73. Macrae M.B., Shannon K.P., Rayner D.M., Kaiser A.M., Hoffman P.N., French G.L. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect. 49:(3):2001;183-192
74. Otman J., Cavassin E.D., Perugini M.E., Vidotto M.C. An outbreak of extended-spectrum beta-lactamase-producing Klebsiella species in a neonatal intensive care unit in Brazil. Infect Control Hosp Epidemiol. 23:(1):2002;8-9
75. Jang T.N., Fung C.P., Yang T.L., Shen S.H., Huang C.S., Lee S.H. Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens infection in a neonatal intensive care unit. J Hosp Infect. 48:(1):2001;13-19
76. Jones B.L., Gorman L.J., Simpson J., et al. An outbreak of Serratia marcescens in two neonatal intensive care units. J Hosp Infect. 46:(4):2000;314-319
77. Assadian O., Berger A., Aspock C., Mustafa S., Kohlhauser C., Hirschl A.M. Nosocomial outbreak of Serratia marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 23:(8):2002;457-461
78. Fleisch F., Zimmermann-Baer U., Zbinden R., et al. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis. 34:(6):2002;767-773
79. Prasad G.A., Jones P.G., Michaels J., Garland J.S., Shivpuri C.R. Outbreak of Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 22:(5):2001;303-305
80. Villari P., Crispino M., Salvadori A., Scarcella A. Molecular epidemiology of an outbreak of Serratia marcescens in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 22:(10):2001;630-634
81. Pillay T., Pillay D.G., Adhikari M., Pillay A., Sturm A.W. An outbreak of neonatal infection with Acinetobacter linked to contaminated suction catheters. J Hosp Infect. 43:(4):1999;299-304
82. Casewell M., Phillips I. Hands as route of transmission for Klebsiella species. BMJ. 2:(6098):1977;1315-1317
83. Knittle M.A., Eitzman D.V., Baer H. Role of hand contamination of personnel in the epidemiology of gram- negative nosocomial infections. J Pediatr. 86:(3):1975;433-437
84. Guenthner S.H., Hendley J.O., Wenzel R.P. Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol. 25:(3):1987;488-490
85. Pittet D., Dharan S., Touveneau S., Sauvan V., Perneger T.V. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med. 159:(8):1999;821-826
86. Pittet D., Hugonnet S., Harbarth S., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet. 356:(9238):2000;1307-1312
87. Hedderwick S.A., McNeil S.A., Lyons M.J., Kauffman C.A. Pathogenic organisms associated with artificial fingernails worn by healthcare workers. Infect Control Hosp Epidemiol. 21:(8):2000;505-509
88. Foca M., Jakob K., Whittier S., et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med. 343:(10):2000;695-700
89. Moolenaar R.L., Crutcher J.M., San Joaquin V.H., et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? [see comments] Infect Control Hosp Epidemiol. 21:(2):2000;80-85
90. Trick W.E., Vernon M.O., Hayes R.A., et al. Impact of ring wearing on hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis. 36:(11):2003;1383-1390
91. Davin-Regli A., Monnet D., Saux P., et al. Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J Clin Microbiol. 34:(6):1996;1474-1480
92. Yuan M., Aucken H., Hall L.M., Pitt T.L., Livermore D.M. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother. 41:(5):1998;527-539
93. Chetchotisakd P., Phelps C.L., Hartstein A.I. Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis. 18:(6):1994;929-937
94. D'Agata E., Venkataraman L., DeGirolami P., Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting. J Clin Microbiol. 35:(10):1997;2602-2605
95. Flynn D.M., Weinstein R.A., Nathan C., Gaston M.A., Kabins S.A. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis. 156:(2):1987;363-368
96. Olson B., Weinstein R.A., Nathan C., Chamberlin W., Kabins S.A. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis. 150:(6):1984;808-816
97. Leverstein-van Hall M.A., Box A.T., Blok H.E., Paauw A., Fluit A.C., Verhoef J. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis. 186:(1):2002;49-56
98. Wu T.L., Chia J.H., Su L.H., Kuo A.J., Chu C., Chiu C.H. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol. 41:(10):2003;4836-4838
99. D'Agata E.M., Venkataraman L., DeGirolami P., et al. Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. [see comments] Crit Care Med. 27:(6):1999;1090-1095
100. Toltzis P., Hoyen C., Spinner-Block S., Salvator A.E., Rice L.B. Factors that predict preexisting colonization with antibiotic-resistant gram-negative bacilli in patients admitted to a pediatric intensive care unit. Pediatrics. 103:(4 Pt 1):1999;719-723
101. Toltzis P., Blumer J.L. Nosocomial acquisition and transmission of antibiotic-resistant gram-negative organisms in the pediatric intensive care unit. Pediatr Infect Dis J. 20:(6):2001;612-618
102. Benno Y., Sawada K., Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol. 28:1984;975-986
103. Balmer S.E., Scott P.H., Wharton B.A. Diet and faecal flora in the newborn: lactoferrin. Arch Dis Child. 64:(12):1989;1685-1690
104. Balmer S.E., Wharton B.A. Diet and faecal flora in the newborn: breast milk and infant formula. Arch Dis Child. 64:(12):1989;1672-1677
105. Hokama T., Imamura T. Members of the throat microflora among infants with different feeding methods. J Trop Pediatr. 44:(2):1998;84-86
106. Goldmann D.A., Leclair J., Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr. 93:(2):1978;288-293
107. Goldmann D.A. Bacterial colonization and infection in the neonate. Am J Med. 70:1981;417-422
108. Finelli L., Livengood J.R., Saiman L. Surveillance of pharyngeal colonization: detection and control of serious bacterial illness in low birth weight infants. Pediatr Infect Dis J. 13:(10):1994;854-859
109. Eriksson M., Melen B., Myrback K.E., Winbladh B., Zetterstrom R. Bacterial colonization of newborn infants in a neonatal intensive care unit. Acta Paediatr Scand. 71:(5):1982;779-783
110. Savey A., Fleurette J., Salle B.L. An analysis of the microbial flora of premature neonates. J Hosp Infect. 21:(4):1992;275-289
111. Tullus K., Fryklund B., Berglund B., Kallenius G., Burman L.G. Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect. 11:(4):1988;349-356
112. Schwiertz A., Gruhl B., Lobnitz M., Michel P., Radke M., Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res. 54:(3):2003;393-399
113. Millar M.R., Linton C.J., Cade A., Glancy D., Hall M., Jalal H. Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotizing enterocolitis. J Clin Microbiol. 34:(10):1996;2506-2510
114. Favier C.F., Vaughan E.E., De Vos W.M., Akkermans A.D. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol. 68:(1):2002;219-226
115. Vollaard E.J., Clasener H.A. Colonization resistance. Antimicrob Agents Chemother. 38:(3):1994;409-414
116. Almuneef M.A., Baltimore R.S., Farrel P.A., Reagan-Cirincione P., Dembry L.M. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis. 32:(2):2001;220-227
117. Toltzis P., Dul M.J., Hoyen C., et al. The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics. 110:(4):2002;707-711
118. Crossley K. Long-term care facilities as sources of antibiotic-resistant nosocomial pathogens. Curr Opin Infect Dis. 14:(4):2001;455-459
119. Bonomo R.A. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis. 31:(6):2000;1414-1422
120. Muder R.R., Brennen C., Drenning S.D., Stout J.E., Wagener M.M. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol. 18:(12):1997;809-813
121. Strausbaugh L.J., Crossley K.B., Nurse B.A., Thrupp L.D. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol. 17:(2):1996;129-140
122. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 281:(6):1999;517-523
123. Mylotte J.M., Goodnough S., Tayara A. Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: tetrospective and prospective surveillance. Am J Infect Control. 29:(3):2001;139-144
124. Lidsky K., Hoyen C., Salvator A., Rice L.B., Toltzis P. Antibiotic-resistant gram-negative organisms in pediatric chronic-care facilities. Clin Infect Dis. 34:(6):2002;760-766